ArticleFrontiers in oncology2026
Preoperative prediction of serosal invasion in gastric cancer using multiphase contrast-enhanced CT radiomics.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to develop and validate a radiomics-based model using multiphase contrast-enhanced CT for the preoperative prediction of serosal invasion in gastric cancer, and to evaluate whether the integration of clinical and CT morphological features could further improve predictive performance. Methods: A retrospective analysis was conducted on 183 patients with surgically confirmed gastric cancer. All patients underwent multiphase CT (arterial, venous, and delayed phases). Radiomic features were extracted from volumetric regions of interest (VOIs). After feature selection and radiomics model construction, a combined nomogram was developed incorporating independent clinical and imaging predictors. Models were evaluated in training and validation cohorts using AUC, accuracy, sensitivity, and specificity. Results: The arterial plus delayed (AP+DP) phase radiomics model demonstrated the best performance, with AUCs of 0.8256 and 0.8179 in the training and validation sets, respectively. Multivariate analysis identified serum CA724 levels and serosal stranding as independent predictors. The combined nomogram incorporating these factors and the radiomics signature achieved AUCs of 0.8626 and 0.8641 in the training and validation sets, respectively. A clinical model was also established, with AUCs of 0.7738 and 0.7654 for the training and validation sets. Conclusion: A radiomics model based on AP+DP CT phases shows strong potential for predicting serosal invasion in GC.The integration of CA72-4 and serosal stranding further increased the AUC of the combined model. The combined model achieved a statistically significant improvement in AUC over the clinical model in the training set, providing a non-invasive tool to support preoperative decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.